Largest companies by market cap
market cap
| Company | Market cap | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 201 | $225.75M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 202 | $223.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 203 | $218.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 204 | $214.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 205 | $214.35M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 206 | $209.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 207 | $199.41M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 208 | $197.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 209 | $192.21M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 210 | $191.24M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 211 | $189.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 212 | $186.35M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 213 | $179.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 214 | $177.57M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 215 | $169.80M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 216 | $162.34M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 217 | $160.86M | Healthcare | Pharmaceuticals | United States | NYSE |
| 218 | $157.92M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 219 | $144.03M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 220 | $140.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 221 | $136.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 222 | $133.84M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 223 | $133.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 224 | $129.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 225 | $129.25M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 226 | $124.26M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 227 | $120.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 228 | $116.82M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 229 | $115.67M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 230 | $115.33M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 231 | $111.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 232 | $111.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 233 | $106.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 234 | $103.36M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 235 | $101.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 236 | $99.03M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 237 | $96.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 238 | $95.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 239 | $95.51M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 240 | $93.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 241 | $90.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 242 | $88.28M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 243 | $84.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 244 | $82.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 245 | $81.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 246 | $81.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 247 | $79.94M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 248 | $79.02M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 249 | $77.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 250 | $77.25M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 251 | $76.11M | Healthcare | Pharmaceuticals | United States | NYSE |
| 252 | $75.24M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 253 | $72.70M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 254 | $71.77M | Healthcare | Pharmaceuticals | United States | NYSE |
| 255 | $70.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 256 | $69.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 257 | $69.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 258 | $69.23M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 259 | $68.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 260 | $67.46M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 261 | $66.88M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 262 | $65.55M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 263 | $62.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 264 | $61.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 265 | $60.84M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 266 | $59.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 267 | $59.45M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 268 | $59.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 269 | $58.80M | Healthcare | Pharmaceuticals | United States | NYSE |
| 270 | $57.36M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 271 | $55.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 272 | $52.33M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 273 | $52.16M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 274 | $51.05M | Healthcare | Pharmaceuticals | United States | NYSE |
| 275 | $48.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 276 | $46.23M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 277 | $46.05M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 278 | $45.97M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 279 | $45.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 280 | $44.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 281 | $44.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 282 | $43.05M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 283 | $42.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 284 | $41.35M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 285 | $41.22M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 286 | $40.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 287 | $40.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 288 | $39.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 289 | $37.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 290 | $37.10M | Healthcare | Pharmaceuticals | United States | NYSE |
| 291 | $36.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 292 | $36.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 293 | $35.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 294 | $34.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 295 | $34.78M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 296 | $30.76M | Healthcare | Pharmaceuticals | United States | NYSE |
| 297 | $29.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 298 | $28.95M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 299 | $28.33M | Healthcare | Pharmaceuticals | United States | NYSE |
| 300 | $27.94M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 409 companies. Market capitalization in USD.